1. Home
  2. EVLV vs GHRS Comparison

EVLV vs GHRS Comparison

Compare EVLV & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.97

Market Cap

988.3M

Sector

Technology

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$12.95

Market Cap

892.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
GHRS
Founded
2013
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
988.3M
892.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EVLV
GHRS
Price
$6.97
$12.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$9.13
$30.11
AVG Volume (30 Days)
2.9M
247.9K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,501,000.00
N/A
Revenue This Year
$41.14
N/A
Revenue Next Year
$14.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.16
N/A
52 Week Low
$2.64
$6.72
52 Week High
$8.91
$20.50

Technical Indicators

Market Signals
Indicator
EVLV
GHRS
Relative Strength Index (RSI) 56.64 39.07
Support Level $6.52 $13.94
Resistance Level $6.78 $15.00
Average True Range (ATR) 0.24 0.84
MACD 0.13 -0.22
Stochastic Oscillator 80.58 3.83

Price Performance

Historical Comparison
EVLV
GHRS

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: